American Vanguard (AVD) 8-K American Vanguard Reports Second Quarter & Mid-year 2012 Results

Exhibit 99.1

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS SECOND QUARTER & MID-YEAR 2012 RESULTS

Performance Reflects Continuing Strong Market Demand and Successful Operational Execution

Newport Beach, CA – August 2, 2012 – American Vanguard Corporation (NYSE:AVD), today announced financial results for the second quarter and six month period ended June 30, 2012.

Fiscal 2012 Second Quarter Financial Highlights – versus Fiscal 2011 Second Quarter:

• Net sales improved from $80.1 million to $84.8 million, an increase of 6%

• Net income improved from $6.0 million to $8.7 million, an increase of 46%

• Earnings per diluted share were $0.30 versus $0.22 in the prior year

Fiscal 2012 First Half Financial Highlights – versus Fiscal 2011 First Half

• Net sales improved from $146.1 million to $172.1 million, an increase of 18%

• Net income improved from $11.0 million to $17.5 million, an increase of 59%

• Earnings per diluted share were $0.61 versus $0.40 in the prior year

Note: Complete details are available in the financial schedules attached to this press release

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “We are pleased to report performance for the second quarter and the first half of 2012 that reflects strong demand for our products and improved profitability of this business. This is consistent with a continued interest in our conventional chemistries as part of Integrated Pest Management. Many of our products are used at the time of planting or early in the growing season and have been relatively unaffected by the persistent drought that has affected the Midwest and Southwest United States. Our successful sales, marketing and operating efforts have driven our bottom-line, net income to just over 10% of net sales (for the quarter) and boosted gross profit margins to 45% for the quarter and 44% for the first half of 2012.”

Mr. Wintemute continued: “We continue to strengthen our already healthy balance sheet, by controlling inventory levels, carefully managing our receivable collections and reducing our long-term debt with scheduled quarterly payments. At mid-year we reported $48 million in cash on the balance sheet and stockholder’s equity of $206 million – a 10% increase during the last 6 months. We have not borrowed against our revolving-line-of-credit for over a year and have adequate cash and credit availability for working capital and other needs.”

Mr. Wintemute concluded: “We are well positioned to take advantage of favorable market conditions for the balance of the year. Factors that will affect our relative success in the third quarter include continued demand for our post-harvest Metam soil fumigants, sufficient pest pressure to support our Bidrin^® foliar cotton insecticide, favorable weather conditions for cotton harvest in support of our Folex^® harvest defoliant, and wet weather in regions where our mosquito adulticide, Dibrom, is used. Further, despite dry weather during the 2012 corn growing season, we continue to see strong demand for our products in anticipation of the 2013 season.”

Conference Call

Eric Wintemute, Chairman & CEO and David Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 12:00 pm EDT / 9:00 am PDT on Thursday, August 2, 2012. Interested parties may participate in the call by dialing (201) 493-6744 please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via theNews and Media section of the Company’s web site atwww.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000^® and Russell 3000^® Indexes as well as the S&P Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site atwww.amvac-chemical.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in the conference call referenced in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

CONTACT:	-OR-	AVD’S INVESTOR RELATIONS FIRM
American Vanguard Corporation		The Equity Group Inc.
William A. Kuser, Director of Investor Relations		www.theequitygroup.com
(949) 260-1200		Lena Cati
williamk@amvac-chemical.com		Lcati@equityny.com
		mailto:(212) 836-961

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(In thousands, except per share data)

(Unaudited)

	For the three months ended June 30						For the six months ended June 30
	2012			2011			2012			2011
Net sales	$	84,837		$	80,062		$	172,092		$	146,095
Cost of sales		46,491			48,381			96,368			87,503
Gross profit		38,346			31,681			75,724			58,592
Operating expenses		24,104			20,998			47,080			38,722
Operating income		14,242			10,683			28,644			19,870
Interest expense		721			978			1,456			1,785
Interest capitalized		(112	)		(16	)		(148	)		(74	)
Extinguishment of debt		—			—			—			546
Income before income tax		13,633			9,721			27,336			17,613
Income tax expense		4,889			3,714			9,858			6,594
Net income		8,744			6,007			17,478			11,019
Change in fair value of interest rate swaps		24			(700	)		46			(946	)
Foreign currency translation adjustment		(420	)		197			122			434
Comprehensive income	$	8,348		$	5,504		$	17,646		$	10,507
Earnings per common share—basic	$	.31		$	.22		$	.63		$	.40
Earnings per common share—assuming dilution	$	.30		$	.22		$	.61		$	.40
Weighted average shares outstanding—basic		27,858			27,548			27,740			27,538
Weighted average shares outstanding—assuming dilution		28,737			27,838			28,544			27,813

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

ASSETS (note 7)

	June 30, 2012			Dec. 31, 2011
	(Unaudited)			(Note)
Current assets:
Cash	$	48,048		$	35,085
Receivables:
Trade, net of allowance for doubtful accounts of $561 and $340, respectively		72,774			68,611
Other		886			1,187
		73,660			69,798
Inventories		79,922			71,068
Prepaid expenses		4,429			2,311
Income taxes receivable		—			203
Total current assets		206,059			178,465
Property, plant and equipment, net		48,449			39,273
Intangible assets		113,059			116,189
Other assets		4,077			5,214
	$	371,644		$	339,141
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current installments of long-term debt	$	15,051		$	14,460
Current installments of other liabilities		1,072			1,038
Accounts payable		23,837			23,214
Deferred revenue		201			7,571
Accrued program costs		57,734			25,910
Accrued expenses and other payables		6,143			6,832
Income taxes payable		30			—
Total current liabilities		104,068			79,025
Long-term debt, excluding current installments		41,027			51,917
Other liabilities, excluding current installments		5,563			5,955
Deferred income taxes		15,172			15,172
Total liabilities		165,830			152,069
Commitments and contingent liabilities
Stockholders’ equity:
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued		—			—
Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 30,158,615 shares at June 30, 2012 and 29,845,047 shares at December 31, 2011		3,016			2,985
Additional paid-in capital		48,411			45,966
Accumulated other comprehensive loss		(2,082	)		(2,250	)
Retained earnings		159,622			143,524
		208,967			190,225
Less treasury stock, at cost, 2,260,996 shares at June 30, 2012 and at December 31, 2011		(3,153	)		(3,153	)
Total stockholders’ equity		205,814			187,072
	$	371,644		$	339,141

Note: The balance sheet at December 31, 2011 has been derived from the audited financial statements at that date.

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

For The Six Months Ended June 30, 2012 and 2011

(Unaudited)

Increase (decrease) in cash	2012			2011
Cash flows from operating activities:
Net income	$	17,478		$	11,019
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of fixed and intangible assets		7,046			6,733
Amortization of other long term assets		1,574			1,934
Amortization of discounted liabilities		396			988
Stock-based compensation		1,031			1,031
Tax benefit from exercise of stock options		(160	)		—
Changes in assets and liabilities associated with operations:
Increase in net receivables		(3,862	)		(41,019	)
Increase in inventories		(8,854	)		(6,566	)
Increase in prepaid expenses and other assets		(2,555	)		(1,791	)
Decrease in income tax receivable/payable, net		393			8,133
Increase in accounts payable		668			9,089
Decrease in deferred revenue		(7,370	)		(5,474	)
Increase in other liabilities		30,883			18,220
Net cash provided by operating activities		36,668			2,297
Cash flows from investing activities:
Capital expenditures		(13,061	)		(2,322	)
Net cash used in investing activities		(13,061	)		(2,322	)
Cash flows from financing activities:
Net repayments under line of credit agreement		—			(7,300	)
Principal payments on long-term debt		(4,000	)		(4,004	)
Tax benefit from exercise of stock options		160
Borrowings on long-term debt		—			20,063
Decrease in other notes payable		(6,827	)		—
Payment of cash dividends		(1,380	)		(826	)
Proceeds from the issuance of common stock (sale of stock under ESPP and exercise of stock option)		1,285			550
Net cash (used in) provided by financing activities		(10,762	)		8,483
Net increase in cash		12,845			8,458
Cash and cash equivalents at beginning of year		35,085			1,158
Effect of exchange rate changes on cash		118			342
Cash and cash equivalents as of June 30	$	48,048		$	9,958